Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Immunogenicity and Safety of Dtpw-Hepb-Hib (Prp-T) Vaccine (Pentavac) in Infants Aged 2–7 Months: A Post Marketing Phase 4 Clinical Trial Study
Elham Ahmadnezhad
Elham Ahmadnezhad

Associate Professor of Epidemiology

National Institute for Health Research

Tehran University of Medical Sciences

All Documents
2. Universal Health Coverage in Iran: The Way Forward, Medical Journal of the Islamic Republic of Iran (2025)
20. Safety and Efficacy of Paxlovid in Covid-19 Treatment: A Rapid Review, Health Technology Assessment in Action (2022)
32. Universal Health Coverage in Iran: What Kind of Knowledge Is Needed to Achieve the Goals?, Medical Journal of the Islamic Republic of Iran (2019)